Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
GDC-0068 (RG7440): Pan-AKT Inhibition and Spatial mTORC1 Con
2026-07-06
Explore how GDC-0068 (RG7440) enables advanced mapping of pan-AKT signaling and mTORC1 compartmentalization. This article uniquely bridges molecular selectivity and spatial pathway analysis for more precise cancer research.
-
Cefoperazone Sodium Salt: Spectrum, Mechanism, and Assay Int
2026-07-06
Cefoperazone sodium salt is a semisynthetic cephalosporin antibiotic with robust activity against gram-negative bacilli and significant β-lactamase stability. Its pharmacokinetics and efficacy benchmarks support its use in in vitro antimicrobial activity assays and biliary tract infection research. This article details its molecular properties and practical application parameters for research workflows.
-
Vorinostat (SAHA): Precision Epigenetic Modulation in Oncolo
2026-07-05
Explore how Vorinostat (suberoylanilide hydroxamic acid) enables targeted epigenetic modulation in oncology, with a special focus on mechanistic insights and practical assay design. This article offers a deeper comparative perspective for cancer biology research.
-
Sprayable Hydrogel Nanoparticle Delivery of Etoposide to Bra
2026-07-04
This study introduces a bioadhesive, sprayable hydrogel system incorporating etoposide and olaparib polymer-coated nanoparticles for localized post-surgical treatment of glioblastoma. The platform demonstrates promising drug release, diffusion, and tissue bioadhesion properties, addressing key challenges in overcoming the blood-brain barrier and improving local chemotherapy efficacy.
-
Lipid Peroxidation (MDA) Assay Kit: Precision in Ferroptosis
2026-07-03
The Lipid Peroxidation (MDA) Assay Kit enables precise, dual-mode detection of malondialdehyde, driving breakthrough insights into oxidative stress and ferroptosis in disease models. Advanced workflows and troubleshooting strategies make this kit the gold standard for reliable lipid peroxidation measurement, empowering researchers to dissect mechanisms underlying drug resistance and cellular injury.
-
PCI-32765 (Ibrutinib): Advancing BTK Inhibition in B-Cell Re
2026-07-03
PCI-32765 (Ibrutinib) empowers high-resolution dissection of B-cell receptor signaling with nanomolar potency and unmatched selectivity. Researchers leverage its robust pharmacology for reproducible studies in chronic lymphocytic leukemia and autoimmune disease models, while APExBIO’s manufacturing rigor ensures translational confidence.
-
Proteinase K: Broad-Spectrum Serine Protease for DNA Integri
2026-07-02
Proteinase K from APExBIO sets the benchmark for genomic DNA isolation and protein hydrolysis workflows, combining robust contaminant removal with exceptional DNA preservation. Its recombinant design and thermal stability deliver reproducible results even across complex sample types, empowering researchers to tackle challenging molecular biology assays with confidence.
-
Proteinase K: Broad-Spectrum Serine Protease for DNA Prep Ex
2026-07-02
Harness the power of Proteinase K for contaminant-free, high-integrity genomic DNA extraction—even in challenging samples. APExBIO’s recombinant enzyme stands out for its robust activity, workflow flexibility, and proven compatibility with advanced proteomic and nucleic acid research.
-
MMP-2/9 Inhibition Preserves BBB in Arsenic-Induced Cognitiv
2026-07-01
This study demonstrates that sodium arsenite impairs learning and memory in male mice via MMP-2 and MMP-9-mediated blood-brain barrier (BBB) disruption and neuronal apoptosis. Doxycycline hyclate, as a matrix metalloproteinases inhibitor, mitigated these effects, highlighting MMP-2/9 as potential therapeutic targets and offering mechanistic insight into arsenic neurotoxicity.
-
Latrunculin A: Reversible Inhibitor of Actin Assembly in Cel
2026-07-01
Latrunculin A from APExBIO delivers precise, reversible actin cytoskeleton disruption for advanced cell morphology and virus–host interaction studies. This guide details actionable experimental workflows, troubleshooting strategies, and insights from cutting-edge proteomic research.
-
Cytochalasin D: Unveiling New Frontiers in Actin Polymerizat
2026-06-30
Explore the multifaceted roles of Cytochalasin D as a potent actin polymerization inhibitor, delving into its mechanisms, translational applications, and the latest cellular uptake insights that differentiate its use in advanced research. Discover how new findings reshape practical assay design and protocol optimization.
-
MK-2206 dihydrochloride (A3010): Reliable Akt Pathway Inhibi
2026-06-30
This article guides biomedical researchers through real-world challenges in apoptosis, proliferation, and cytotoxicity assays, demonstrating how MK-2206 dihydrochloride (SKU A3010) offers reproducible, data-driven solutions. Drawing on robust experimental evidence and best practices, it details protocol optimization and vendor selection to maximize reliability in Akt pathway modulation.
-
Proteinase K: Broad-Spectrum Serine Protease for DNA Integri
2026-06-29
APExBIO's recombinant Proteinase K powers high-yield, contaminant-free DNA extraction even in challenging samples. With robust activity and inhibitor resistance, it enables reliable protein hydrolysis and enzyme removal for molecular biology workflows.
-
AZD2461: Novel PARP Inhibitor for DNA Repair Modulation
2026-06-29
AZD2461 is a potent, novel PARP inhibitor that targets DNA repair pathways and demonstrates nanomolar efficacy in breast cancer cell models. Its low P-glycoprotein affinity enables the circumvention of drug resistance, making it a valuable tool for cancer biology research. AZD2461’s robust in vitro and in vivo data support its role in advancing studies of PARP inhibitor resistance mechanisms.
-
IR-820 (New Indocyanine Green): Advancing In Vivo NIR Imagin
2026-06-28
IR-820 (New Indocyanine Green) is a specialized near-infrared dye used for high-sensitivity vascular and tumor imaging in animal models. Its robust fluorescence and stability make it a preferred agent for in vivo quantification of diseased tissues. APExBIO supplies this agent for research use only, not for diagnostic applications.